Study: Marketing opioids to doctors tied to increased overdose deaths
Researchers looked at the connections between the amount of marketing to doctors and opioid overdose deaths in a study published in JAMA.
Marketing Research
Survey: Millennials just don’t trust their doctors
Healthcare companies will have to rethink how they communicate online with millennials as the generation makes more healthcare decisions.
Big Predictions: Agency gurus on the future of data in the industry
We asked some of the agency world’s sharpest data people to answer a pair of questions about the future of data in and around pharma marketing. Here’s what they had to say.
MM&M’s Data Week: Demystifying one of pharma’s biggest pain points
It was at an MM&M event back in late 2013 that I got my first glimpse of how this industry feels about big data.
Real-world evidence: It’s finally having its moment
Fueled by system-wide demand and facilitated by AI, the industry’s lofty expectations around real-world evidence could soon be fulfilled
Machine Learning Can Decipher Data
As researchers and analysts, we interact with a wide array of market research pros in the health and wellness space.
How Do Docs Learn About New Drugs? TV, Of Course
If asked, some will equivocate and say they get their facts from medical journals and from published studies, but never from those pesky misleading ads.
4 Ways to Create a Dialogue With Patients Without Costly Studies
How can marketers incorporate patient feedback into their marketing strategies without expensive and time-consuming studies?
Leadership Exchange: Social Listening
Social listening can help all along the value chain—from research and discovery to developing marketing plans and strategy.
Five things for pharma marketers to know: Tuesday, June 23
Adults dominate the ADHD prescription category; the FDA approved The Medicine Company’s anticlotting drug 10 years after issuing a CRL; a survey shows personalized content can build consumer goodwill
